ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Posted on by Raj Gaurav Rai

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related Posts

RBI Draft Guidelines on Project under implementationMajorly negative for project financiers followed by PSU banksAdditional prov. requirement can impact the net-worth by 4%/6%/7% for PFC/REC/IREDAPSU Banks – credit costs to rise by 10-15 bps over FY25-27 RBI Draft Guidelines on Project under implementationMajorly negative for project financiers followed by PSU banksAdditional prov. requirement can impact the net-worth by 4%/6%/7% for PFC/REC/IREDAPSU Banks – credit costs to rise by 10-15 bps over FY25-27

RBI Draft Guidelines on Project under implementation Majorly negative for project financiers followed by PSU banks Additional prov. requirement can impact the net-worth by 4%/6%/7% […]